tiprankstipranks
Trending News
More News >
Brainsway Ltd (BWAY)
NASDAQ:BWAY
US Market
Advertisement

Brainsway (BWAY) Earnings Dates, Call Summary & Reports

Compare
300 Followers

Earnings Data

Report Date
Mar 11, 2026
TBA (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.04
Last Year’s EPS
0.04
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 11, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
BrainsWay's Q3 2025 earnings call indicated strong growth and positive developments, including record revenue, increased system shipments, and successful strategic investments. Despite increased operating expenses and a delay in FDA clearance for Neurolief, the company's performance and raised guidance reflect a generally optimistic outlook.
Company Guidance
During BrainsWay's Third Quarter 2025 Earnings Conference Call, the company reported record quarterly revenue of $13.5 million, marking a 29% increase from the previous year. Additionally, 90 Deep TMS systems were shipped, reflecting a 43% year-over-year growth. As a result, the company raised its full-year revenue guidance to a range of $51 million to $52 million, an increase from the prior $50 million to $52 million. Operating profit is now expected to be between 6% and 7% of revenue, up from the previous 4% to 5%, while adjusted EBITDA is projected to be in the range of 13% to 14%, an improvement from the initially anticipated 12% to 13%. BrainsWay's strategic focus on multiyear lease agreements has led to approximately 70% of recent customer engagements being lease-based, contributing to high customer retention and a book-to-bill ratio of 1.3x. The company also reported a remaining performance obligation of $65 million and mentioned a positive cash flow from operations.
Record Quarterly Revenue
BrainsWay reported a record quarterly revenue of $13.5 million for Q3 2025, representing a 29% increase compared to the same period last year.
Increased Deep TMS Shipments
The company shipped 90 Deep TMS systems during the quarter, marking a 43% increase compared to the same period last year, bringing the total installed base to over 1,600 systems globally.
Raised Financial Guidance
BrainsWay raised its full-year 2025 revenue guidance to $51 million to $52 million, up from the previous guidance of $50 million to $52 million. Operating profit guidance was also increased to 6% to 7% of revenue.
FDA Approval for Accelerated Protocol
The U.S. FDA granted an expansion for the Deep TMS system to include an accelerated protocol for major depressive disorder, shortening the treatment phase significantly.
Successful Strategic Investments
The company made significant minority interest investments in mental health providers, seeing utilization of Deep TMS systems increase by over 50% in some clinics.
Strong Financial Performance
Gross profit for the quarter was $10.2 million, up from $7.7 million in the prior year, with a strong gross margin of 75%.

Brainsway (BWAY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BWAY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 11, 2026
2025 (Q4)
0.04 / -
0.04
Nov 11, 2025
2025 (Q3)
0.05 / 0.04
0.02100.00% (+0.02)
Aug 13, 2025
2025 (Q2)
0.03 / 0.05
0.02150.00% (+0.03)
May 13, 2025
2025 (Q1)
0.02 / 0.02
0
Mar 11, 2025
2024 (Q4)
0.02 / 0.04
0
Nov 12, 2024
2024 (Q3)
0.01 / 0.02
-0.01300.00% (+0.03)
Aug 06, 2024
2024 (Q2)
>-0.01 / 0.02
-0.05140.00% (+0.07)
May 08, 2024
2024 (Q1)
-0.02 / 0.00
-0.07
Mar 06, 2024
2023 (Q4)
-0.01 / 0.00
-0.12
Nov 15, 2023
2023 (Q3)
-0.04 / -0.01
-0.1593.33% (+0.14)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BWAY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 11, 2025
$16.12$15.18-5.83%
Aug 13, 2025
$12.19$12.70+4.18%
May 13, 2025
$8.83$9.81+11.10%
Mar 11, 2025
$9.19$9.62+4.68%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Brainsway Ltd (BWAY) report earnings?
Brainsway Ltd (BWAY) is schdueled to report earning on Mar 11, 2026, TBA (Confirmed).
    What is Brainsway Ltd (BWAY) earnings time?
    Brainsway Ltd (BWAY) earnings time is at Mar 11, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BWAY EPS forecast?
          BWAY EPS forecast for the fiscal quarter 2025 (Q4) is 0.04.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis